JPWO2022270628A1 - - Google Patents
Info
- Publication number
- JPWO2022270628A1 JPWO2022270628A1 JP2023530145A JP2023530145A JPWO2022270628A1 JP WO2022270628 A1 JPWO2022270628 A1 JP WO2022270628A1 JP 2023530145 A JP2023530145 A JP 2023530145A JP 2023530145 A JP2023530145 A JP 2023530145A JP WO2022270628 A1 JPWO2022270628 A1 JP WO2022270628A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021106034 | 2021-06-25 | ||
| PCT/JP2022/025361 WO2022270628A1 (ja) | 2021-06-25 | 2022-06-24 | Ｒｓウイルス感染症の処置および／または予防用医薬としてのヘテロシクロアルキル置換ポリヘテロアゾール誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022270628A1 true JPWO2022270628A1 (https=) | 2022-12-29 |
Family
ID=84545504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023530145A Pending JPWO2022270628A1 (https=) | 2021-06-25 | 2022-06-24 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240327392A1 (https=) |
| EP (1) | EP4361148A4 (https=) |
| JP (1) | JPWO2022270628A1 (https=) |
| CN (1) | CN117730079A (https=) |
| AU (1) | AU2022296214A1 (https=) |
| CA (1) | CA3223875A1 (https=) |
| WO (1) | WO2022270628A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025206404A1 (ja) * | 2024-03-29 | 2025-10-02 | 国立大学法人 大分大学 | 線維症治療のための抗線維化化合物 |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015506348A (ja) * | 2011-12-22 | 2015-03-02 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン |
| WO2015198263A2 (en) * | 2014-06-26 | 2015-12-30 | Hetero Research Foundation | Novel betulinic proline substituted derivatives as hiv inhibitors |
| WO2016001820A1 (en) * | 2014-06-30 | 2016-01-07 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 抗ウイルス性アザ糖を含有するヌクレオシド |
| JP2017537118A (ja) * | 2014-12-08 | 2017-12-14 | ヤンセン・サイエンシズ・アイルランド・ユーシー | Ｒｓウイルス（ｒｓｖ）複製の阻害活性を有するピペリジン置換ピラゾロ［１，５−ａ］ピリミジン誘導体 |
| WO2018051255A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators |
| WO2018051254A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL140040A0 (en) * | 1998-06-03 | 2002-02-10 | Guilford Pharm Inc | N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres |
| DOP2000000107A (es) * | 1999-12-01 | 2002-09-16 | Agouron Pharmaceutical Inc | Compuestos, composiciones y metodos para estimular el crecimiento y alongamiento de las neuronas |
| US6589978B2 (en) * | 2000-06-30 | 2003-07-08 | Hoffman-La Roche Inc. | 1-sulfonyl pyrrolidine derivatives |
| JP4221989B2 (ja) * | 2002-09-30 | 2009-02-12 | 大正製薬株式会社 | オキサジアゾール誘導体 |
| JP4240978B2 (ja) * | 2002-09-30 | 2009-03-18 | 大正製薬株式会社 | アリールオキシメチルオキサジアゾール誘導体 |
| JP2006523669A (ja) * | 2003-03-10 | 2006-10-19 | ファイザー・インク | Ｎｉｍａ調節タンパク質（ｐｉｎ１）を阻害するための、リン酸／硫酸エステル化合物および医薬組成物 |
| EP1604989A1 (en) * | 2004-06-08 | 2005-12-14 | Santhera Pharmaceuticals (Deutschland) Aktiengesellschaft | DPP-IV inhibitors |
| EP1981845A2 (en) * | 2006-02-08 | 2008-10-22 | Wyeth | Sulfonamide derivatives to treat infection with hepatitis c virus |
| MX2012007420A (es) * | 2009-12-24 | 2012-07-23 | Vertex Pharma | Analogos para el tratamiento o prevencion de infecciones de flavivirus. |
| CN102869657A (zh) * | 2010-03-24 | 2013-01-09 | 沃泰克斯药物股份有限公司 | 用于治疗或预防黄病毒感染的类似物 |
| US9637516B2 (en) * | 2012-12-31 | 2017-05-02 | Hetero Research Foundation | Betulinic acid proline derivatives as HIV inhibitors |
| JP6862305B2 (ja) | 2017-07-13 | 2021-04-21 | 株式会社マキタ | 衣服及び報知システム |
| RU2712097C1 (ru) * | 2018-09-28 | 2020-01-24 | Общество с ограниченной ответственностью "Необиотек" | Ингибитор дипептидилпептидазы-4 для лечения сахарного диабета 2-го типа, соединения (варианты) |
| JP7684282B2 (ja) * | 2020-03-31 | 2025-05-27 | 田辺三菱製薬株式会社 | ヒドロキシピロリジン誘導体およびその医薬用途 |
-
2022
- 2022-06-24 US US18/573,760 patent/US20240327392A1/en active Pending
- 2022-06-24 CA CA3223875A patent/CA3223875A1/en active Pending
- 2022-06-24 EP EP22828544.1A patent/EP4361148A4/en active Pending
- 2022-06-24 CN CN202280044481.9A patent/CN117730079A/zh active Pending
- 2022-06-24 AU AU2022296214A patent/AU2022296214A1/en active Pending
- 2022-06-24 JP JP2023530145A patent/JPWO2022270628A1/ja active Pending
- 2022-06-24 WO PCT/JP2022/025361 patent/WO2022270628A1/ja not_active Ceased
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015506348A (ja) * | 2011-12-22 | 2015-03-02 | ギリアード サイエンシーズ， インコーポレイテッド | 抗ウイルス剤としてのピラゾロ［１，５−ａ］ピリミジン |
| JP2016504284A (ja) * | 2012-11-16 | 2016-02-12 | バイオクリスト ファーマスーティカルズ，インコーポレイテッドＢｉｏｃｒｙｓｔ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． | 抗ウイルス性アザ糖を含有するヌクレオシド |
| WO2015198263A2 (en) * | 2014-06-26 | 2015-12-30 | Hetero Research Foundation | Novel betulinic proline substituted derivatives as hiv inhibitors |
| WO2016001820A1 (en) * | 2014-06-30 | 2016-01-07 | Hetero Research Foundation | Novel betulinic proline imidazole derivatives as hiv inhibitors |
| JP2017537118A (ja) * | 2014-12-08 | 2017-12-14 | ヤンセン・サイエンシズ・アイルランド・ユーシー | Ｒｓウイルス（ｒｓｖ）複製の阻害活性を有するピペリジン置換ピラゾロ［１，５−ａ］ピリミジン誘導体 |
| WO2018051255A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators |
| WO2018051254A1 (en) * | 2016-09-14 | 2018-03-22 | Aurigene Discovery Technologies Limited | Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators |
Non-Patent Citations (1)
| Title |
|---|
| KANG, IOU-JIUN ET AL.: "A potent, selective, and orally bioavailable HCV NS5A inhibitor for treatment of Hepatitis C Virus:", JOURNAL OF MEDICINAL CHEMISTRY, vol. 60, JPN6022038513, 2017, pages 228 - 247, ISSN: 0005834392 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4361148A1 (en) | 2024-05-01 |
| EP4361148A4 (en) | 2025-07-09 |
| CA3223875A1 (en) | 2022-12-29 |
| AU2022296214A1 (en) | 2024-01-25 |
| WO2022270628A1 (ja) | 2022-12-29 |
| US20240327392A1 (en) | 2024-10-03 |
| CN117730079A (zh) | 2024-03-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20240319 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250624 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260407 |